<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81849</article-id><article-id pub-id-type="doi">10.7554/eLife.81849</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-214056"><name><surname>Hay</surname><given-names>James A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1998-1844</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177325"><name><surname>Kissler</surname><given-names>Stephen M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3062-7800</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-289357"><name><surname>Fauver</surname><given-names>Joseph R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-289356"><name><surname>Mack</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-289355"><name><surname>Tai</surname><given-names>Caroline G</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-289371"><name><surname>Samant</surname><given-names>Radhika M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-289372"><name><surname>Connolly</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-289358"><name><surname>Anderson</surname><given-names>Deverick J</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-289359"><name><surname>Khullar</surname><given-names>Gaurav</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-289360"><name><surname>MacKay</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-289361"><name><surname>Patel</surname><given-names>Miral</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-289362"><name><surname>Kelly</surname><given-names>Shannan</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-289363"><name><surname>Manhertz</surname><given-names>April</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf13"/></contrib><contrib contrib-type="author" id="author-289364"><name><surname>Eiter</surname><given-names>Isaac</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf14"/></contrib><contrib contrib-type="author" id="author-289365"><name><surname>Salgado</surname><given-names>Daisy</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf15"/></contrib><contrib contrib-type="author" id="author-289366"><name><surname>Baker</surname><given-names>Tim</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf16"/></contrib><contrib contrib-type="author" id="author-289367"><name><surname>Howard</surname><given-names>Ben</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf17"/></contrib><contrib contrib-type="author" id="author-289368"><name><surname>Dudley</surname><given-names>Joel T</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf18"/></contrib><contrib contrib-type="author" id="author-289373"><name><surname>Mason</surname><given-names>Christopher E</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf19"/></contrib><contrib contrib-type="author" id="author-289369"><name><surname>Nair</surname><given-names>Manoj</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5994-3957</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289370"><name><surname>Huang</surname><given-names>Yaoxing</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289374"><name><surname>DiFiori</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf20"/></contrib><contrib contrib-type="author" id="author-256285"><name><surname>Ho</surname><given-names>David D</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-227252"><name><surname>Grubaugh</surname><given-names>Nathan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf21"/></contrib><contrib contrib-type="author" corresp="yes" id="author-37494"><name><surname>Grad</surname><given-names>Yonatan H</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5646-1314</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf22"/></contrib><aff id="aff1"><institution>Harvard TH Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Yale School of Public Health</institution>, <addr-line><named-content content-type="city">New Haven</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>IQVIA</institution>, <addr-line><named-content content-type="city">Durham</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution>Duke Center for Antimicrobial Stewardship and Infection Prevention</institution>, <addr-line><named-content content-type="city">Durham</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>Tempus Labs</institution>, <addr-line><named-content content-type="city">Chicago</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Vagelos College of Physicians and Surgeons</institution>, <institution>Columbia University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution>Hospital for Special Surgery</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-123836"><name><surname>Rodriguez-Barraquer</surname><given-names>Isabel</given-names></name><role>Reviewing editor</role><aff><institution>University of California, San Francisco</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>grubaughlab@gmail.com</email> (NG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>ygrad@hsph.harvard.edu</email> (YG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>11</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e81849</elocation-id><history><date date-type="received"><day>13</day><month>07</month><year>2022</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Hay et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Hay et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81849-v1.pdf"/><abstract><p><bold>Background:</bold> The combined impact of immunity and SARS-CoV-2 variants on viral kinetics during infections has been unclear.</p><p><bold>Methods:</bold> We characterized 1,280 infections from the National Basketball Association occupational health cohort identified between June 2020 and January 2022 using serial RT-qPCR testing. Logistic regression and semi-mechanistic viral RNA kinetics models were used to quantify the effect of age, variant, symptom status, infection history, vaccination status and antibody titer to the founder SARS-CoV-2 strain on the duration of potential infectiousness and overall viral kinetics. The frequency of viral rebounds was quantified under multiple cycle threshold (Ct) value-based definitions.</p><p><bold>Results:</bold> Among individuals detected partway through their infection, 51.0% (95% credible interval [CrI]: 48.3-53.6%) remained potentially infectious (Ct&lt;30) five days post detection, with small differences across variants and vaccination status. Only seven viral rebounds (0.7%; N=999) were observed, with rebound defined as 3+ days with Ct&lt;30 following an initial clearance of 3+ days with Ct≥30. High antibody titers against the founder SARS-CoV-2 strain predicted lower peak viral loads and shorter durations of infection. Among Omicron BA.1 infections, boosted individuals had lower pre-booster antibody titers and longer clearance times than non-boosted individuals.</p><p><bold>Conclusions:</bold> SARS-CoV-2 viral kinetics are partly determined by immunity and variant but dominated by individual-level variation. Since booster vaccination protects against infection, longer clearance times for BA.1-infected, boosted individuals may reflect a less effective immune response, more common in older individuals, that increases infection risk and reduces viral RNA clearance rate. The shifting landscape of viral kinetics underscores the need for continued monitoring to optimize isolation policies and to contextualize the health impacts of therapeutics and vaccines.</p><p><bold>Funding:</bold> Supported in part by CDC contract #200-2016-91779, a sponsored research agreement to Yale University from the National Basketball Association contract #21-003529, and the National Basketball Players Association.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000030</institution-id><institution>Centers for Disease Control and Prevention</institution></institution-wrap></funding-source><award-id>200-2016-91779</award-id><principal-award-recipient><name><surname>Grad</surname><given-names>Yonatan H</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>National Basketball Association</institution></institution-wrap></funding-source><award-id>21-003529</award-id><principal-award-recipient><name><surname>Grubaugh</surname><given-names>Nathan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Stephen M Kissler, SMK has a consulting agreement with the NBA.</p></fn><fn fn-type="conflict" id="conf3"><p>Joseph R Fauver, has a consulting agreement for Tempus and receives financial support from Tempus to develop SARS-CoV-2 diagnostic tests.</p></fn><fn fn-type="conflict" id="conf4"><p>Christina Mack, is an employee of IQVIA, Real World Solutions.</p></fn><fn fn-type="conflict" id="conf5"><p>Caroline G Tai, is an employee of IQVIA, Real World Solutions.</p></fn><fn fn-type="conflict" id="conf6"><p>Radhika M Samant, is an employee of IQVIA, Real World Solutions.</p></fn><fn fn-type="conflict" id="conf7"><p>Sarah Connolly, is an employee of IQVIA, Real World Solutions.</p></fn><fn fn-type="conflict" id="conf8"><p>Deverick J Anderson, is co-owner of Infection Control Education for Major Sports.</p></fn><fn fn-type="conflict" id="conf9"><p>Gaurav Khullar, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf10"><p>Matthew MacKay, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf11"><p>Miral Patel, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf12"><p>Shannan Kelly, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf13"><p>April Manhertz, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf14"><p>Isaac Eiter, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf15"><p>Daisy Salgado, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf16"><p>Tim Baker, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf17"><p>Ben Howard, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf18"><p>Joel T Dudley, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf19"><p>Christopher E Mason, is an employee of Tempus Labs.</p></fn><fn fn-type="conflict" id="conf20"><p>John DiFiori, is an employee of the NBA.</p></fn><fn fn-type="conflict" id="conf21"><p>Nathan Grubaugh, has a consulting agreement for Tempus and receives financial support from Tempus to develop SARS-CoV-2 diagnostic tests.</p></fn><fn fn-type="conflict" id="conf22"><p>Yonatan H Grad, has a consulting agreement with the NBA.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All code and data required to reproduce the analyses are available at https://github.com/gradlab/SC2-kinetics-immune-history.</p></sec></sec></back></article>